PRESS RELEASE published on 06/24/2024 at 23:00, 1 year 7 months ago Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF published on 05/28/2024 at 23:05, 1 year 8 months ago Medicure Reports Financial Results for Q1 2024 and Director Election Results Financial Results Director Election Q1 2024 Medicure
BRIEF published on 05/28/2024 at 23:05, 1 year 8 months ago Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs Résultats Financiers Médicament T1 2024 Élection Du Directeur
PRESS RELEASE published on 05/28/2024 at 23:00, 1 year 8 months ago Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF published on 04/23/2024 at 23:05, 1 year 9 months ago Medicure reçoit la désignation Fast Track de la FDA pour le traitement MC-1 du déficit en PNPO Medicure Inc. Désignation De Médicament Orphelin Désignation Fast Track De La FDA MC-1 Carence En PNPO
BRIEF published on 04/23/2024 at 23:05, 1 year 9 months ago Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency
PRESS RELEASE published on 04/23/2024 at 23:00, 1 year 9 months ago Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF published on 04/08/2024 at 23:05, 1 year 10 months ago Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRIEF published on 04/08/2024 at 23:05, 1 year 10 months ago Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE published on 04/08/2024 at 23:00, 1 year 10 months ago Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023 Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis
Published on 02/12/2026 at 14:00, 10 minutes ago Diamond Drilling Confirms Wide Gold Intercept in Northeast Extension of North Pipe at Colosseum
Published on 02/12/2026 at 14:00, 10 minutes ago Kinross to Initiate Two Phase 6,000-8,000 Metre Drill Program on BTU Dixie Halo Property Near Great Bear Property
Published on 02/12/2026 at 14:00, 10 minutes ago A Court-Appointed Annual General Meeting of Gold Basin Shareholders Has Been Called for March 16, 2026
Published on 02/12/2026 at 13:30, 40 minutes ago Jericho Energy Ventures (TSXV:JEV) Announces Letter of Intent with Comstock Holding Companies (Nasdaq:CHCI) to Advance AI Data Center Campus Development Leveraging Its Energy Infrastructure; Comstock to Invest USD$1.5 Million in Private Placement
Published on 02/12/2026 at 13:00, 1 hour 10 minutes ago Matador Technologies Inc. Announces Participation in Premier 2026 Bitcoin and Technology Conferences as It Advances Bitcoin Treasury Growth Strategy
Published on 02/12/2026 at 13:35, 34 minutes ago SMT Scharf AG drives strategic business development forward with targeted measures
Published on 02/12/2026 at 13:35, 35 minutes ago ITALY, TRADE SHOWS: KEY 2026, TECHNOLOGIES AND INNOVATIONS FOR CLEAN ENERGY IN RIMINI
Published on 02/12/2026 at 13:04, 1 hour 6 minutes ago BIRKENSTOCK ANNOUNCES THAT IT MAINTAINS ITS FINANCIAL GUIDANCE FOR FISCAL YEAR 2026 (ENDING SEPTEMBER 30, 2026)
Published on 02/12/2026 at 07:30, 6 hours 40 minutes ago Press release - Carrefour announces the sale of Carrefour Romania
Published on 02/12/2026 at 07:30, 6 hours 40 minutes ago Communiqué de presse - Carrefour annonce la cession de Carrefour Roumanie
Published on 02/12/2026 at 07:00, 7 hours 10 minutes ago TERACT - Chiffre d’affaires du 1er semestre 2025-2026
Published on 02/11/2026 at 17:45, 20 hours 25 minutes ago Infotel : Stake held in AeroEx. A publisher of digital compliance and safety solutions for the aerospace industry.